| Literature DB >> 34266694 |
Mary Frances Wedekind1, Brigitte C Widemann2, Gregory Cote3.
Abstract
Chordoma is a rare tumor that occurs along the axial spine in pediatrics and adults, with an incidence of approximately 350 cases per year in the United States. While typically described as slow-growing, many patients will eventually develop loco-regional relapse or metastatic disease with few treatment options. Despite numerous efforts over the last 10+ years, effective treatments for patients are lacking. As subtypes of chordoma are identified and described in more detail, further knowledge regarding the natural history of each type, tumor location, age differences, genomic variability, and an overall better understanding of chordoma may be the key to developing meaningful clinical trials and effective therapies for patients with chordoma.Entities:
Keywords: Chordoma; Conventional chordoma; Dedifferentiated chordoma; Immunotherapy; Poorly differentiated chordoma
Mesh:
Year: 2021 PMID: 34266694 DOI: 10.1016/j.currproblcancer.2021.100771
Source DB: PubMed Journal: Curr Probl Cancer ISSN: 0147-0272 Impact factor: 3.187